C

CRISP-HR Therapeutics, Inc.

3 employees

CRISP-HR a therapeutics company has developed a proprietary, next-generation CRISPR platform to create novel therapeutics for rare diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Cellular Therapeutics
Cas9-HR Platform
Stem Cell
Life Science
Cas9 Fusion Proteins
Cas9-HR
Gene Editing Platforms
Double Strand Break (DSB)
DNA Editing
Genetic Engineering
Cas9
Health Sciences
Immunotherapeutics
Immune
Therapeutics
Genomic Editing
Life Sciences
Metabolic
Medicine
DNA
Homologous Recombination
CRISPR

Date founded

2019

Funding rounds raised

C

CRISP-HR Therapeutics, Inc. raised undisclosed on March 16, 2022

Investors: Illumina For Startups

FAQ